CD19 and non-Hodgkin lymphoma: CAR-T cells are typically generated from autologous lymphocytes through viral vector transduction and are engineered to target specific antigens, such as CD19 in B-ALL and non-Hodgkin lymphomas or B-cell maturation antigen (BCMA) in MM.